JP2016526535A5 - - Google Patents

Download PDF

Info

Publication number
JP2016526535A5
JP2016526535A5 JP2016519625A JP2016519625A JP2016526535A5 JP 2016526535 A5 JP2016526535 A5 JP 2016526535A5 JP 2016519625 A JP2016519625 A JP 2016519625A JP 2016519625 A JP2016519625 A JP 2016519625A JP 2016526535 A5 JP2016526535 A5 JP 2016526535A5
Authority
JP
Japan
Prior art keywords
difluoro
substituted
ethynyl
tetrazol
difluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016519625A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016526535A (ja
JP6386035B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/041984 external-priority patent/WO2014201161A1/en
Publication of JP2016526535A publication Critical patent/JP2016526535A/ja
Publication of JP2016526535A5 publication Critical patent/JP2016526535A5/ja
Application granted granted Critical
Publication of JP6386035B2 publication Critical patent/JP6386035B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016519625A 2013-06-12 2014-06-11 金属酵素阻害剤化合物 Expired - Fee Related JP6386035B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361834324P 2013-06-12 2013-06-12
US61/834,324 2013-06-12
PCT/US2014/041984 WO2014201161A1 (en) 2013-06-12 2014-06-11 Metalloenzyme inhibitor compounds

Publications (3)

Publication Number Publication Date
JP2016526535A JP2016526535A (ja) 2016-09-05
JP2016526535A5 true JP2016526535A5 (enExample) 2017-06-22
JP6386035B2 JP6386035B2 (ja) 2018-09-05

Family

ID=52022749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016519625A Expired - Fee Related JP6386035B2 (ja) 2013-06-12 2014-06-11 金属酵素阻害剤化合物

Country Status (9)

Country Link
US (1) US9688671B2 (enExample)
EP (1) EP3008051A4 (enExample)
JP (1) JP6386035B2 (enExample)
KR (1) KR20160018811A (enExample)
CN (1) CN105431418B (enExample)
AU (1) AU2014278172B2 (enExample)
CA (1) CA2915054A1 (enExample)
EA (1) EA201690007A1 (enExample)
WO (1) WO2014201161A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS57248B1 (sr) 2011-12-11 2018-07-31 Viamet Pharmaceuticals Nc Inc Jedinjenja inhibitori metaloenzima
IN2014DN06792A (enExample) * 2012-01-20 2015-05-22 Viamet Pharmaceuticals Inc
JP6572234B2 (ja) 2014-03-19 2019-09-04 ヴィアメット ファーマスーティカルズ(エヌシー),インコーポレイテッド 抗真菌化合物の調製方法
JP2017509646A (ja) 2014-03-19 2017-04-06 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
CA2942968C (en) 2014-03-19 2022-03-15 William J. Hoekstra Antifungal compound process
CN109678791B (zh) 2014-03-19 2022-07-01 美国陶氏益农公司 1-(2,4-二氟苯)-2,2-二氟-2-(5-取代吡啶-2-基)乙酮及制备方法
US10196375B2 (en) 2014-03-19 2019-02-05 Mycovia Pharmaceuticals, Inc. Antifungal compound process
US10017494B2 (en) 2014-03-19 2018-07-10 Mycovia Pharmaceuticals, Inc. Antifungal compound process
WO2015143154A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
US9914726B2 (en) 2014-03-19 2018-03-13 Vps-3, Inc. 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and processes for their preparation
JP2017507991A (ja) 2014-03-19 2017-03-23 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
MA40943A (fr) 2014-11-10 2017-09-19 Constellation Pharmaceuticals Inc Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
MA40940A (fr) 2014-11-10 2017-09-19 Constellation Pharmaceuticals Inc Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
JP6639497B2 (ja) 2014-11-10 2020-02-05 ジェネンテック, インコーポレイテッド ブロモドメインインヒビターおよびその使用
WO2016123391A1 (en) 2015-01-29 2016-08-04 Genentech, Inc. Therapeutic compounds and uses thereof
BR112018005194B1 (pt) 2015-09-18 2022-11-08 Vps-3, Inc Processo para preparar um composto antifúngico
MX376201B (es) * 2015-12-30 2025-03-07 Nqp 1598 Ltd Compuestos inhibidores de metaloenzima.
WO2019173188A1 (en) 2018-03-05 2019-09-12 Arcus Biosciences, Inc. Arginase inhibitors
WO2020092139A1 (en) * 2018-10-29 2020-05-07 Huahai Us Inc. Novel dipeptide compounds and uses thereof
EP3880685B1 (en) 2018-11-16 2025-06-18 Arcus Biosciences, Inc. Inhibitors of arg1 and/or arg2
US20220380317A1 (en) 2019-06-27 2022-12-01 Nanyang Technological University Compounds having antimalarial activity
CN110885323A (zh) * 2019-12-02 2020-03-17 中国人民解放军第二军医大学 一种三氮唑醇类衍生物、其制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080062876A (ko) * 2006-12-29 2008-07-03 주식회사 대웅제약 신규한 항진균성 트리아졸 유도체
SI2563771T1 (sl) 2010-04-24 2016-05-31 Viamet Pharmaceuticals, Inc. Spojine inhibitorjev metaloencimov
KR20140040235A (ko) * 2011-06-19 2014-04-02 비아멧 파마슈티컬즈, 인코포레이티드 금속효소 억제제 화합물
WO2012177635A1 (en) * 2011-06-19 2012-12-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
JP2014523880A (ja) * 2011-06-23 2014-09-18 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 金属酵素化合物
RS57248B1 (sr) * 2011-12-11 2018-07-31 Viamet Pharmaceuticals Nc Inc Jedinjenja inhibitori metaloenzima

Similar Documents

Publication Publication Date Title
JP6386035B2 (ja) 金属酵素阻害剤化合物
US11247981B2 (en) Metalloenzyme inhibitor compounds
AU2011242562B2 (en) Metalloenzyme inhibitor compounds
US10919874B2 (en) Metalloenzyme inhibitor compounds